Billionaire Profile
Phillip Frost
Global Rank
#1799

Image: Unsplash Contributor | Unsplash License | via Unsplash

Phillip Frost

CEO, Pharmaceuticals
UNITED STATES
Real-Time Net Worth
$2.341B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
0% (24h)
Age
89
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
UNITED STATES

Biography

Phillip Frost is a prominent American physician, inventor, and entrepreneur, primarily known for his contributions to the pharmaceutical industry and his extensive philanthropic endeavors. Born in 1936, Frost's career began as a dermatologist, and he later transitioned into business, founding and leading successful companies such as IVAX Corporation and OPKO Health, Inc.. His source of wealth is primarily from pharmaceuticals. Frost is recognized for his role in developing generic drugs and medical diagnostics. Beyond his business achievements, Frost is celebrated for his significant charitable contributions to education, science, and the arts. His net worth is estimated at $2.4 Billion.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Phillip Frost was born in Philadelphia, Pennsylvania, to an observant Jewish family. At a young age, he took his first job working in a hardware shop. Frost pursued higher education, earning a B.A. in French literature from the University of Pennsylvania in 1957. He furthered his studies at the University of Paris from 1955 to 1956. Frost then obtained an M.D. degree from the Albert Einstein College of Medicine in 1961.

Rise to Success

Frost began his career in medicine and served as a Lieutenant Commander in the U.S. Public Health Service at the National Cancer Institute. Later, he joined the faculty at the University of Miami's School of Medicine and became the chair of the Department of Dermatology at Mount Sinai Medical Center in Miami. Frost's entrepreneurial journey commenced with Key Pharmaceuticals, which he acquired and developed into a successful drug company. In 1987, he founded IVAX Corporation, a pharmaceutical company. Frost's leadership and innovation have been instrumental in the pharmaceutical sector, particularly in generic drug development. He currently serves as CEO and Chairman of OPKO Health, Inc..

Key Business Strategies

A key strategy in Frost's career was his focus on bringing beneficial drugs to market and expanding healthcare options. Frost’s ability to identify promising pharmaceutical opportunities and his strategic investments have been central to his success.

Philanthropy

Phillip Frost and his wife, Patricia, are renowned philanthropists who have contributed significantly to various causes. Their donations include $33 million to the School of Music at the University of Miami, which was renamed the Phillip and Patricia Frost School of Music. They also contributed $35 million to the construction of the Phillip and Patricia Frost Museum of Science. Additionally, The Frosts have recently initiated a scholarship program for graduates of Florida state universities and Israeli universities to study at Oxford University in England. Frost has made significant donations to the arts, science, and education.

Career Milestones

1961

Earned MD

Received a medical degree from the Albert Einstein College of Medicine.

1966

Joined University of Miami

Became a faculty member at the University of Miami School of Medicine.

1970

Acquired Key Pharmaceuticals

Acquired Key Pharmaceuticals, a small public company.

1987

Founded IVAX Corporation

Founded IVAX Corporation and served as CEO.

2007

CEO of OPKO Health

Became CEO and Chairman of OPKO Health, Inc.

Philanthropy & Social Impact

Education

Frost School of Music

$33M

Donation to the University of Miami, which was renamed the Phillip and Patricia Frost School of Music.

Science

Frost Museum of Science

$35M

Contribution to the construction of the Phillip and Patricia Frost Museum of Science.

Education

Oxford University Scholarships

Unknown

Initiated a scholarship program for Florida and Israeli university graduates to study at Oxford.

Business Philosophy & Leadership

Notable Quotes

"I really don't know that there's any particular item I would do over."

Leadership Principles

Innovation

Committed to bringing beneficial drugs to market and expanding healthcare options.

Philanthropy

Generous contributions to various causes, including education, science, and the arts.

Controversies & Challenges

2019

SEC Settlement

Agreed to pay $5.5 million to settle stock 'pump-and-dump' charges with the Securities and Exchange Commission.